Exact Mass: 401.1618434

Exact Mass Matches: 401.1618434

Found 100 metabolites which its exact mass value is equals to given mass value 401.1618434, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

2-(1-carboxy-2-hydroxypropyl)-4-{[5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl}-3-methyl-3,4-dihydro-2h-pyrrole-5-carboxylic acid

2-(1-Carboxy-2-hydroxypropyl)-4-{[5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulphanyl}-3-methyl-3,4-dihydro-2H-pyrrole-5-carboxylic acid

C17H27N3O6S (401.1620482)


   

Ghrelin agonist HM01

3-[1-(2,3-dichloro-4-methoxyphenyl)ethyl]-1-methyl-1-(1,3,3-trimethylpiperidin-4-yl)urea

C19H29Cl2N3O2 (401.1636714)


   

Ipsapirone

2-{4-[4-(pyrimidin-2-yl)piperazin-1-yl]butyl}-2,3-dihydro-1λ⁶,2-benzothiazole-1,1,3-trione

C19H23N5O3S (401.15215280000007)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist Ipsapirone (TVX Q 7821) is an anxiolytic compound and a 5-HT1A receptor partial agonist. Ipsapirone (TVX Q 7821) also exhibits 5-HT1A receptor antagonistic effect, and only at high doses it can also produce an inhibitory effect on 5-HT2 and the α1-adrenergic function[1][2].

   

Setoperone

6-{2-[4-(4-fluorobenzoyl)piperidin-1-yl]ethyl}-7-methyl-2H,3H,5H-[1,3]thiazolo[3,2-a]pyrimidin-5-one

C21H24FN3O2S (401.1573176)


   
   
   
   
   
   
   
   

1-Pyridylhydroxybutyl-deoxyinosine

1-Pyridylhydroxybutyl-deoxyinosine

C19H23N5O5 (401.1699108)


   

Meropenem Metabolite (2H-Pyrrole-2-acetic acid, 5-carboxy-4-[[(3S,5S)-5-[(dimethylamino)carbonyl]-3-

Meropenem Metabolite (2H-Pyrrole-2-acetic acid, 5-carboxy-4-[[(3S,5S)-5-[(dimethylamino)carbonyl]-3-

C17H27N3O6S (401.1620482)


   

Asp Gly Asn Pro

(2S)-1-[(2S)-2-{2-[(2S)-2-amino-3-carboxypropanamido]acetamido}-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C15H23N5O8 (401.1546558)


   

Asp Gly Pro Asn

(3S)-3-amino-3-({2-[(2S)-2-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}pyrrolidin-1-yl]-2-oxoethyl}carbamoyl)propanoic acid

C15H23N5O8 (401.1546558)


   

Asp Asn Gly Pro

(2S)-1-{2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carbamoylpropanamido]acetyl}pyrrolidine-2-carboxylic acid

C15H23N5O8 (401.1546558)


   

Asp Asn Pro Gly

(3S)-3-amino-3-{[(2S)-3-carbamoyl-1-[(2S)-2-[(carboxymethyl)carbamoyl]pyrrolidin-1-yl]-1-oxopropan-2-yl]carbamoyl}propanoic acid

C15H23N5O8 (401.1546558)


   

Asp Pro Gly Asn

(3S)-3-amino-4-[(2S)-2-[({[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}methyl)carbamoyl]pyrrolidin-1-yl]-4-oxobutanoic acid

C15H23N5O8 (401.1546558)


   

Asp Pro Asn Gly

(3S)-3-amino-4-[(2S)-2-{[(1S)-2-carbamoyl-1-[(carboxymethyl)carbamoyl]ethyl]carbamoyl}pyrrolidin-1-yl]-4-oxobutanoic acid

C15H23N5O8 (401.1546558)


   

Gly Asp Asn Pro

(2S)-1-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carboxypropanamido]-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C15H23N5O8 (401.1546558)


   

Gly Asp Pro Asn

(3S)-3-(2-aminoacetamido)-4-[(2S)-2-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}pyrrolidin-1-yl]-4-oxobutanoic acid

C15H23N5O8 (401.1546558)


   

Gly Asn Asp Pro

(2S)-1-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]-3-carboxypropanoyl]pyrrolidine-2-carboxylic acid

C15H23N5O8 (401.1546558)


   

Gly Asn Pro Asp

(2S)-2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}butanedioic acid

C15H23N5O8 (401.1546558)


   

Gly Pro Asp Asn

(3S)-3-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-3-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}propanoic acid

C15H23N5O8 (401.1546558)


   

Gly Pro Asn Asp

(2S)-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-3-carbamoylpropanamido]butanedioic acid

C15H23N5O8 (401.1546558)


   
   

Asn Asp Gly Pro

(2S)-1-{2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-carboxypropanamido]acetyl}pyrrolidine-2-carboxylic acid

C15H23N5O8 (401.1546558)


   

Asn Asp Pro Gly

(3S)-3-[(2S)-2-amino-3-carbamoylpropanamido]-4-[(2S)-2-[(carboxymethyl)carbamoyl]pyrrolidin-1-yl]-4-oxobutanoic acid

C15H23N5O8 (401.1546558)


   

Asn Gly Asp Pro

(2S)-1-[(2S)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}-3-carboxypropanoyl]pyrrolidine-2-carboxylic acid

C15H23N5O8 (401.1546558)


   

Asn Gly Pro Asp

(2S)-2-{[(2S)-1-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetyl}pyrrolidin-2-yl]formamido}butanedioic acid

C15H23N5O8 (401.1546558)


   

Asn Pro Asp Gly

(3S)-3-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-[(carboxymethyl)carbamoyl]propanoic acid

C15H23N5O8 (401.1546558)


   

Asn Pro Gly Asp

(2S)-2-(2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}acetamido)butanedioic acid

C15H23N5O8 (401.1546558)


   

Pro Asp Gly Asn

(3S)-3-[({[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}methyl)carbamoyl]-3-[(2S)-pyrrolidin-2-ylformamido]propanoic acid

C15H23N5O8 (401.1546558)


   

Pro Asp Asn Gly

(3S)-3-{[(1S)-2-carbamoyl-1-[(carboxymethyl)carbamoyl]ethyl]carbamoyl}-3-[(2S)-pyrrolidin-2-ylformamido]propanoic acid

C15H23N5O8 (401.1546558)


   

Pro Gly Asp Asn

(3S)-3-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}-3-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}propanoic acid

C15H23N5O8 (401.1546558)


   

Pro Gly Asn Asp

(2S)-2-[(2S)-3-carbamoyl-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}propanamido]butanedioic acid

C15H23N5O8 (401.1546558)


   

Pro Asn Asp Gly

(3S)-3-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-[(carboxymethyl)carbamoyl]propanoic acid

C15H23N5O8 (401.1546558)


   

Pro Asn Gly Asp

(2S)-2-{2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]acetamido}butanedioic acid

C15H23N5O8 (401.1546558)


   
   
   

Lys-Phe-OH

(S)-2-(3-(4-aminobutoxy)-4-nitrobenzamido)-3-phenylpropanoic acid

C20H23N3O6 (401.1586778)


   

Phe-Lys-OH

(S)-7-amino-2-(3-(benzyloxy)-4-nitrobenzamido)heptanoic acid

C20H23N3O6 (401.1586778)


   
   
   

3-(9H-fluoren-9-ylmethoxycarbonylamino)-3-(4-methylphenyl)propanoic acid

3-(9H-fluoren-9-ylmethoxycarbonylamino)-3-(4-methylphenyl)propanoic acid

C25H23NO4 (401.16269980000004)


   

N-Fmoc-erythro-DL-beta-methylphenylalanine

N-Fmoc-erythro-DL-beta-methylphenylalanine

C25H23NO4 (401.16269980000004)


   
   
   
   
   

fmoc-(r)-3-amino-3-(2-methyl-phenyl)-propionic acid

fmoc-(r)-3-amino-3-(2-methyl-phenyl)-propionic acid

C25H23NO4 (401.16269980000004)


   

fmoc-(r)-3-amino-3-(3-methyl-phenyl)-propionic acid

fmoc-(r)-3-amino-3-(3-methyl-phenyl)-propionic acid

C25H23NO4 (401.16269980000004)


   
   
   
   
   
   
   
   
   
   

Setoperone

5H-THIAZOLO[3,2A]PYRIMIDIN-5-ONE, 6-[2-[4-(4-FLUOROBENZOYL)-1-PIPERIDINYL]ETHYL]-2,3-DIHYDRO-7-METHYL-

C21H24FN3O2S (401.1573176)


D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent

   

5-METHOXY-6-METHYL-3-((3-METHYLCYCLOHEXYL)OXY)-N-(2H-TETRAZOL-5-YL)BENZO[B]THIOPHENE-2-CARBOXAMIDE

5-METHOXY-6-METHYL-3-((3-METHYLCYCLOHEXYL)OXY)-N-(2H-TETRAZOL-5-YL)BENZO[B]THIOPHENE-2-CARBOXAMIDE

C19H23N5O3S (401.15215280000007)


   

Fmoc-4-(4-aminophenyl)butanoic acid

Fmoc-4-(4-aminophenyl)butanoic acid

C25H23NO4 (401.16269980000004)


   

fmoc-(s)-3-amino-3-(3-methyl-phenyl)-propionic acid

fmoc-(s)-3-amino-3-(3-methyl-phenyl)-propionic acid

C25H23NO4 (401.16269980000004)


   
   

3-(9 H-FLUOREN-9-YLMETHOXYCARBONYLAMINO)-4-PHENYL-BUTYRIC ACID

3-(9 H-FLUOREN-9-YLMETHOXYCARBONYLAMINO)-4-PHENYL-BUTYRIC ACID

C25H23NO4 (401.16269980000004)


   

TNP 470

O-(chloroacetylcarbamoyl)fumagillol

C19H28ClNO6 (401.16050580000007)


C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C2143 - Endothelial Cell Inhibitor D006133 - Growth Substances > D043924 - Angiogenesis Modulating Agents D000970 - Antineoplastic Agents > D020533 - Angiogenesis Inhibitors D006133 - Growth Substances > D006131 - Growth Inhibitors C471 - Enzyme Inhibitor > C783 - Protease Inhibitor

   

(R)-3-((((9H-FLUOREN-9-YL)METHOXY)CARBONYL)AMINO)-2-BENZYLPROPANOIC ACID

(R)-3-((((9H-FLUOREN-9-YL)METHOXY)CARBONYL)AMINO)-2-BENZYLPROPANOIC ACID

C25H23NO4 (401.16269980000004)


   

(4R,5S)-5-[(1S,2R)-1-Carboxy-2-hydroxypropyl]-3-{[(3S,5S)-5-(dimethylcarbamoyl)-3-pyrrolidinyl]sulfanyl}-4-methyl-4,5-dihydro-1H-pyrrole-2-carboxylic acid

(4R,5S)-5-[(1S,2R)-1-Carboxy-2-hydroxypropyl]-3-{[(3S,5S)-5-(dimethylcarbamoyl)-3-pyrrolidinyl]sulfanyl}-4-methyl-4,5-dihydro-1H-pyrrole-2-carboxylic acid

C17H27N3O6S (401.1620482)


   

FMoc-alpha-Methyl-L-phenylalanine

FMoc-alpha-Methyl-L-phenylalanine

C25H23NO4 (401.16269980000004)


   
   

fmoc-(s)-3-amino-3-(4-methyl-phenyl)-propionic acid

fmoc-(s)-3-amino-3-(4-methyl-phenyl)-propionic acid

C25H23NO4 (401.16269980000004)


   

fmoc-(s)-3-amino-3-(2-methyl-phenyl)-propionic acid

fmoc-(s)-3-amino-3-(2-methyl-phenyl)-propionic acid

C25H23NO4 (401.16269980000004)


   
   
   

fmoc-(r)-3-amino-3-(4-methyl-phenyl)-propionic acid

fmoc-(r)-3-amino-3-(4-methyl-phenyl)-propionic acid

C25H23NO4 (401.16269980000004)


   

L-glutamyl-L-glutamic acid 2-naphthylamide

L-glutamyl-L-glutamic acid 2-naphthylamide

C20H23N3O6 (401.1586778)


   

N-[6-amino-2-[[2-(4-methyl-1-piperidinyl)-2-oxoethyl]thio]-4-oxo-1H-pyrimidin-5-yl]benzamide

N-[6-amino-2-[[2-(4-methyl-1-piperidinyl)-2-oxoethyl]thio]-4-oxo-1H-pyrimidin-5-yl]benzamide

C19H23N5O3S (401.15215280000007)


   

L-Tyrosine, glycyl-L-tyrosyl-

L-Tyrosine, glycyl-L-tyrosyl-

C20H23N3O6 (401.1586778)


   

L-Tyrosylglycyl-L-tyrosine

L-Tyrosylglycyl-L-tyrosine

C20H23N3O6 (401.1586778)


   

[5-(2-Chlorophenyl)-1-pentylpyrrol-3-yl]-naphthalen-1-ylmethanone

[5-(2-Chlorophenyl)-1-pentylpyrrol-3-yl]-naphthalen-1-ylmethanone

C26H24ClNO (401.1546324)


   

N-[3-(6-Phenyl-3H-imidazo[4,5-b]pyridine-2-yl)-4-fluorophenyl]pyrrolidine-1-carboxamide

N-[3-(6-Phenyl-3H-imidazo[4,5-b]pyridine-2-yl)-4-fluorophenyl]pyrrolidine-1-carboxamide

C23H20FN5O (401.1651802)


   

4-fluoro-N-[4-[[[2-(methylamino)-4-quinazolinyl]amino]methyl]phenyl]benzamide

4-fluoro-N-[4-[[[2-(methylamino)-4-quinazolinyl]amino]methyl]phenyl]benzamide

C23H20FN5O (401.1651802)


   
   
   

1-[3-[(7-Cyano-[1,3]dioxolo[4,5-g]quinolin-6-yl)amino]propyl]-3-(3-methoxypropyl)thiourea

1-[3-[(7-Cyano-[1,3]dioxolo[4,5-g]quinolin-6-yl)amino]propyl]-3-(3-methoxypropyl)thiourea

C19H23N5O3S (401.15215280000007)


   

ethyl N-[4-[(4,4-diethyl-2,5-dioxoimidazolidin-1-yl)methyl]-2-oxochromen-7-yl]carbamate

ethyl N-[4-[(4,4-diethyl-2,5-dioxoimidazolidin-1-yl)methyl]-2-oxochromen-7-yl]carbamate

C20H23N3O6 (401.1586778)


   

(1R,5S)-7-[4-[(E)-prop-1-enyl]phenyl]-N-[4-(trifluoromethyl)phenyl]-3,6-diazabicyclo[3.1.1]heptane-3-carboxamide

(1R,5S)-7-[4-[(E)-prop-1-enyl]phenyl]-N-[4-(trifluoromethyl)phenyl]-3,6-diazabicyclo[3.1.1]heptane-3-carboxamide

C22H22F3N3O (401.1714878)


   

[(3aR,4R,9bR)-8-(2-phenylethynyl)-1-(2-thiazolylmethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-4-yl]methanol

[(3aR,4R,9bR)-8-(2-phenylethynyl)-1-(2-thiazolylmethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-4-yl]methanol

C24H23N3OS (401.15617480000003)


   

[(3aS,4S,9bS)-8-(2-phenylethynyl)-1-(2-thiazolylmethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-4-yl]methanol

[(3aS,4S,9bS)-8-(2-phenylethynyl)-1-(2-thiazolylmethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-4-yl]methanol

C24H23N3OS (401.15617480000003)


   

(1S,5R)-7-[4-[(E)-prop-1-enyl]phenyl]-N-[4-(trifluoromethyl)phenyl]-3,6-diazabicyclo[3.1.1]heptane-6-carboxamide

(1S,5R)-7-[4-[(E)-prop-1-enyl]phenyl]-N-[4-(trifluoromethyl)phenyl]-3,6-diazabicyclo[3.1.1]heptane-6-carboxamide

C22H22F3N3O (401.1714878)


   

Ipsapirone

Ipsapirone

C19H23N5O3S (401.15215280000007)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent C78272 - Agent Affecting Nervous System > C47794 - Serotonin Agonist Ipsapirone (TVX Q 7821) is an anxiolytic compound and a 5-HT1A receptor partial agonist. Ipsapirone (TVX Q 7821) also exhibits 5-HT1A receptor antagonistic effect, and only at high doses it can also produce an inhibitory effect on 5-HT2 and the α1-adrenergic function[1][2].

   
   
   

N-Fmoc-N-benzyl-L-alanine

N-Fmoc-N-benzyl-L-alanine

C25H23NO4 (401.16269980000004)


N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N-benzyl-L-alanine is an alanine derivative[1].

   

SHEN26

SHEN26

C19H23N5O5 (401.1699108)


SHEN26 (ATY014) is a potent and orally active RdRp inhibitor, with an IC50 for SARS-CoV-2 is 1.36 μM. SHEN26 is a 5’-cyclohexanecarboxylate derivative of GS-441524 (HY-103586). SHEN26 inhibits viral nucleic acid synthesis to achieve antiviral effects. SHEN26 can be used for the research of coronavirus disease 2019 (COVID-19)[1][2].

   

(3r,4s,5s,6r)-5-methoxy-4-[(3r)-2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl]-1-oxaspiro[2.5]octan-6-yl n-(2-chloro-1-hydroxyethylidene)carbamate

(3r,4s,5s,6r)-5-methoxy-4-[(3r)-2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl]-1-oxaspiro[2.5]octan-6-yl n-(2-chloro-1-hydroxyethylidene)carbamate

C19H28ClNO6 (401.16050580000007)


   

5-methoxy-4-[2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl]-1-oxaspiro[2.5]octan-6-yl n-(2-chloro-1-hydroxyethylidene)carbamate

5-methoxy-4-[2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl]-1-oxaspiro[2.5]octan-6-yl n-(2-chloro-1-hydroxyethylidene)carbamate

C19H28ClNO6 (401.16050580000007)